Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuo Taniguchi

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Cancer Science|February 3, 2007
Genomic profiling of malignant pleural mesothelioma with array-based comparative genomic hybridization shows frequent non-random chromosomal alteration regions including JUN amplification on 1p32Tetsuo Taniguchi, Sivasundaram Karnan, Takayuki Fukui, et al.
Cancer Science|November 24, 2012
TIMELESS is overexpressed in lung cancer and its expression correlates with poor patient survivalKenya Yoshida, Mitsuo Sato, Tetsunari Hase, et al.
International Journal of Cancer|November 11, 2006
RhoB is frequently downregulated in non-small-cell lung cancer and resides in the 2p24 homozygous deletion region of a lung cancer cell lineNaohito Sato, Takayuki Fukui, Tetsuo Taniguchi, et al.
Carcinogenesis|April 22, 2009
Combined inhibition of MET and EGFR suppresses proliferation of malignant mesothelioma cellsKoji Kawaguchi, Hideki Murakami, Tetsuo Taniguchi, et al.
Anticancer Research|January 30, 2026
Prognostic Factors for Pulmonary Metastasectomy for Colorectal Cancer: A Propensity Score Matching AnalysisShoji Okado, Shota Nakamura, Minoru Sugihara, et al.
Cancer Research|November 6, 2009
Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinomaYasuhiro Goto, Keiko Shinjo, Yutaka Kondo, et al.
BMJ Open|December 21, 2021
Multicentre, prospective, observational study investigating the most appropriate surgical option that can prevent the recurrence of primary spontaneous pneumothorax after surgery: the PATCH study, protocolYuka Kadomatsu, Hiromu Yoshioka, Kikuo Shigemitsu, et al.
Journal of Cellular and Molecular Medicine|September 9, 2020
CERS6 required for cell migration and metastasis in lung cancerMotoshi Suzuki, Ke Cao, Seiichi Kato, et al.
The Journal of Clinical Investigation|July 3, 2019
Targeting ceramide synthase 6-dependent metastasis-prone phenotype in lung cancer cellsMotoshi Suzuki, Ke Cao, Seiichi Kato, et al.
The Journal of Clinical Investigation|November 2, 2019
Targeting ceramide synthase 6-dependent metastasis-prone phenotype in lung cancer cellsMotoshi Suzuki, Ke Cao, Seiichi Kato, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Cancer Science|February 3, 2007
Genomic profiling of malignant pleural mesothelioma with array-based comparative genomic hybridization shows frequent non-random chromosomal alteration regions including JUN amplification on 1p32Tetsuo Taniguchi, Sivasundaram Karnan, Takayuki Fukui, et al.
Cancer Science|November 24, 2012
TIMELESS is overexpressed in lung cancer and its expression correlates with poor patient survivalKenya Yoshida, Mitsuo Sato, Tetsunari Hase, et al.
International Journal of Cancer|November 11, 2006
RhoB is frequently downregulated in non-small-cell lung cancer and resides in the 2p24 homozygous deletion region of a lung cancer cell lineNaohito Sato, Takayuki Fukui, Tetsuo Taniguchi, et al.
Carcinogenesis|April 22, 2009
Combined inhibition of MET and EGFR suppresses proliferation of malignant mesothelioma cellsKoji Kawaguchi, Hideki Murakami, Tetsuo Taniguchi, et al.
Anticancer Research|January 30, 2026
Prognostic Factors for Pulmonary Metastasectomy for Colorectal Cancer: A Propensity Score Matching AnalysisShoji Okado, Shota Nakamura, Minoru Sugihara, et al.
Cancer Research|November 6, 2009
Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinomaYasuhiro Goto, Keiko Shinjo, Yutaka Kondo, et al.
BMJ Open|December 21, 2021
Multicentre, prospective, observational study investigating the most appropriate surgical option that can prevent the recurrence of primary spontaneous pneumothorax after surgery: the PATCH study, protocolYuka Kadomatsu, Hiromu Yoshioka, Kikuo Shigemitsu, et al.
Journal of Cellular and Molecular Medicine|September 9, 2020
CERS6 required for cell migration and metastasis in lung cancerMotoshi Suzuki, Ke Cao, Seiichi Kato, et al.
The Journal of Clinical Investigation|July 3, 2019
Targeting ceramide synthase 6-dependent metastasis-prone phenotype in lung cancer cellsMotoshi Suzuki, Ke Cao, Seiichi Kato, et al.
The Journal of Clinical Investigation|November 2, 2019
Targeting ceramide synthase 6-dependent metastasis-prone phenotype in lung cancer cellsMotoshi Suzuki, Ke Cao, Seiichi Kato, et al.
Pageof 6